fosamax lawyers
On October 13, 2010, the U.S. Food and Drug Administration (FDA) issued a femur fracture warning informing patients and well being care providers about the achievable risk of atypical thigh bone (femur) fractures in patients who take bisphosphonates, such as Fosamax. Bisphosphonates are a class of drugs utilised to prevent and treat osteoporosis. Atypical femur fractures, a rare but severe type of thigh bone fracture, have been predominantly reported in patients taking drugs such as Fosamax for longer than five years.
A labeling adjust and Medication Guide for Fosamax, Fosamax Plus D, and their generic merchandise will reflect this latest femur fracture warning by the FDA.
Research Support Femur Fracture Warning
With regard to this femur fracture warning, the FDA stated that it is &ldquocontinuing to evaluate information about the safety and effectiveness of bisphosphonates when utilized extended-term for osteoporosis remedy.&rdquo &ldquoIn the interim, it&rsquos crucial for patients and well being care specialists to have all the safety info obtainable when figuring out the greatest course of remedy for osteoporosis.&rdquo
These days&rsquos femur fracture warning follows a March 10, 2010 Drug Safety Communication announcing the FDA&rsquos ongoing safety evaluation of bisphosphonate use and the occurrence of atypical femur fractures. The FDA has considering that reviewed all readily available information on bisphosphonate use, including data summarized in the American Society for Bone Mineral Investigation Process Force report. The report advised further item labeling, much better identification and tracking of patients experiencing these breaks, and more investigation to establish no matter whether and how these drugs result in the significant but uncommon fractures.
Based on the FDA&rsquos evaluation, the Warnings and Precautions section of all bisphosphonate merchandise for osteoporosis, which includes Fosamax, will be revised to incorporate the femur fracture warning, and the FDA will require the inclusion of the exact same femur fracture warning into a Medication Guide to better inform patients of the possible elevated fracture threat. People who have suffered a femur fracture after taking Fosamax may want to file a fosamax lawsuit.
Given this most recent femur fracture warning, the FDA recommends that well being care experts be aware of the doable threat in patients taking bisphosphonates and contemplate periodic reevaluation of the require for continued bisphosphonate therapy for patients who have been on bisphosphonates for longer than five years.
Patients taking bisphosphonates really should report any new thigh or groin pain to their wellness care provider and be evaluated for a feasible femur fracture. If you or someone you know have suffered a femur fracture after taking Fosamax contact a fosamax lawyer for help.